Pharming Group N.V.(PHAR)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Limited institutional coverage
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 11 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
PHAR Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Pharming Group N.V. (PHAR), a Healthcare sector company. PHAR is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 11 institutional filers currently hold this stock. Top institutional holders of PHAR by reported 13-F value include Silverberg Bernstein Capital Management, MORGAN STANLEY, SmartHarvest Portfolios,, based on the most recent SEC filings. PHAR trades on the Nasdaq exchange and files with the SEC under CIK 1828316. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PHAR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Pharming Group N.V. directly from SEC EDGAR.
Get alerted when PHAR's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Pharming Group N.V. including:
Top Institutional Holders of PHAR
Silverberg Bernstein Capital Management LLC
$744.6K44,747 shMORGAN STANLEY
$191.2K11,489 shSmartHarvest Portfolios, LLC
$179.7K10,797 shCITADEL ADVISORS LLC
$169.5K10,189 shKnoll Capital Management, LLC
$67.5K4,057 shEverSource Wealth Advisors, LLC
$7.6K1,440 shBNP PARIBAS FINANCIAL MARKETS
$6.7K400 shLarson Financial Group LLC
$5.7K343 shOSAIC HOLDINGS, INC.
$2.1K128 shStone House Investment Management, LLC
$1.3K79 sh
| Fund | Value | Shares |
|---|---|---|
| Silverberg Bernstein Capital Management LLC | $744.6K | 44,747 |
| MORGAN STANLEY | $191.2K | 11,489 |
| SmartHarvest Portfolios, LLC | $179.7K | 10,797 |
| CITADEL ADVISORS LLC | $169.5K | 10,189 |
| Knoll Capital Management, LLC | $67.5K | 4,057 |
| EverSource Wealth Advisors, LLC | $7.6K | 1,440 |
| BNP PARIBAS FINANCIAL MARKETS | $6.7K | 400 |
| Larson Financial Group LLC | $5.7K | 343 |
| OSAIC HOLDINGS, INC. | $2.1K | 128 |
| Stone House Investment Management, LLC | $1.3K | 79 |
More Healthcare Companies
View all Healthcare →Put PHAR on your watchlist
Track score changes the day Pharming Group N.V. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is PHAR a good stock to buy?
13F Pro's AI-powered analysis of Pharming Group N.V. (PHAR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PHAR are available on the PHAR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own PHAR?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PHAR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Pharming Group N.V.'s investment landscape.